Search from over 60,000 research works

Advanced Search

Protofibrillar amyloid beta modulation of recombinant hCaV2.2 (N-type) voltage-gated channels

[thumbnail of Open access]
Preview
pharmaceuticals-15-01459.pdf - Published Version (3MB) | Preview
Available under license: Creative Commons Attribution
[thumbnail of Kaisis et al. 2022_author version.docx]
Kaisis et al. 2022_author version.docx - Accepted Version (898kB)
Restricted to Repository staff only
Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Kaisis, E., Thei, L. J., Stephens, G. J. orcid id iconORCID: https://orcid.org/0000-0002-8966-4238 and Dallas, M. L. orcid id iconORCID: https://orcid.org/0000-0002-5190-0522 (2022) Protofibrillar amyloid beta modulation of recombinant hCaV2.2 (N-type) voltage-gated channels. Pharmaceuticals, 15 (12). 1459. ISSN 1424-8247 doi: 10.3390/ph15121459

Abstract/Summary

Cav2.2 channels are key regulators of presynaptic Ca2+ influx and their dysfunction and/or aber-rant regulation has been implicated in many disease states; however, the nature of their involve-ment in Alzheimer’s disease (AD) is less clear. In this short communication, we show that recombinant hCav2.2/beta1b/a2d channels are modulated by human synthetic AD-related protofibrillar amyloid beta Abeta1-42 peptide. Structural studies revealed a time-dependent increase in protofibril length, with the majority of protofibrils less than 100nm at 24hr; while at 48 hr, the majority were longer than 100nm. Cav2.2 modulation by Abeta1-42 was different between a ‘low’ (100nM) and ‘high’ (1µM) concentration in terms of distinct effects on individual biophysical parameters. 100nM Abeta1-42 caused a significant change in the slope factor (k) consistent with improved voltage sensitivity of the channel; by contrast, 1µM Abeta1-42 caused an inhibitory decrease in current density (pA/pF) and maximum conductance (Gmax). These data highlight a differential modulation of Cav2.2 channels by Abeta1-42 peptide. Discrete changes in presynaptic Ca2+ flux have been reported to occur at an early stage of AD; therefore, this study has implications for targeting Cav2.2 in the AD pathology and reveals a potential mechanistic link between amyloid accumulation and Cav2.2 channel modulation.

Altmetric Badge

Item Type Article
URI https://reading-clone.eprints-hosting.org/id/eprint/109167
Item Type Article
Refereed Yes
Divisions Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Division of Pharmacology
Publisher MDPI
Download/View statistics View download statistics for this item

Downloads

Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record

Search Google Scholar